Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Diabetes Mellitus, Type 2 3Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Disease 1

Interventions

X-Rays 2Telemedicine 1Sulfonylurea Compounds 1Standard of Care 1Sodium-Glucose Transporter 2 Inhibitors 1Pulmonary Surgical Procedures 1Palliative Care 1Methods 1Massage 1Magnesium Sulfate 1Lysine Acetyltransferase 5 1Dipeptidyl-Peptidase IV Inhibitors 1Cyclosporine 1Calorimetry, Indirect 1CIMAvax EGF 1Bronchoscopy 1Bronchoalveolar Lavage 1Blood Specimen Collection 1Behavior Therapy 1Accelerometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pulmonary Disease, Chronic Obstructive × Sulfonylurea Compounds × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡